Dr. Stanton is Chief of the Kidney and Hypertension Section at the Joslin Diabetes Center, Staff Physician at Beth Israel Deaconess Medical Center, and an Associate Professor of Medicine at Harvard Medical School. Dr. Stanton maintains a robust clinical practice as well as being a researcher and educator. Dr. Stanton has given many invited lectures throughout the world and written many original articles and reviews on clinical and basic science aspects of diabetic kidney disease. Dr. Stanton’s research has focused on oxidative stress, cellular survival, and diabetic complications. In particular, Dr. Stanton’s laboratory has studied an essential enzyme that plays a major role in regulating multiple cellular functions, glucose 6-phosphate dehydrogenase (G6PD). His laboratory has discovered that G6PD is essential for cell survival and dysregulation of G6PD plays an important role in the pathogenesis of many diseases including diabetes mellitus, diabetic kidney disease, diabetic vascular disease, and hyperaldosteronism. Dr. Stanton serves on the Professional Practice Committee of the American Diabetes Association (ADA Guideline Committee) and oversees the Chronic Kidney Guidelines Section. Dr. Stanton is also very involved with teaching at all levels, and he has received Honorary Professorships and teaching awards including a lifetime-achievement teaching award for Sustained Excellence in Teaching from Harvard Medical School.